Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Portugal

Coordination and Support Action · Running

BreastScreening-AI The First Multimodal GenAI Platform Delivering Precision Breast Cancer Diagnosis

Coordinator
Sensiperception Lda, Portugal
Runs
1 July 2026 to 31 December 2027
Status
Running
EU funding
€490k
Total cost
—
Partners
1 organisations in 1 countries
Type
Coordination and Support Action
Grant agreement
101310071

What the project is doing

In the project's own words, from its summary on CORDIS.

BreastScreening-AI is a multimodal, explainable GenAI platform designed to improve accuracy, speed, and reliability in breast cancer diagnostics. Built by SensiPerception, a deep-tech spin-off from Instituto Superior Técnico, the system integrates mammography, ultrasound, and MRI into a single predictive pipeline using cross-attention deep-learning models trained on a large, expert-annotated multicentre dataset. Unlike existing single-modality AI tools, it delivers real-time, BIRADS-aligned assessments enriched with adaptive, user-tailored explanations, supporting both junior and senior radiologists.

The solution addresses persistent diagnostic challenges - false positives up to 40%, false negatives around 10%, and growing radiologist shortages - while operating seamlessly within PACS environments without requiring new hardware. Retrospective validation on >15,000 patient cases showed a 50% reduction in false positives, 60% reduction in false negatives, a fourfold increase in radiologist throughput, and a reduction of diagnostic time from 11 minutes to under 3.The EIC Pre-Accelerator will enable BreastScreening-AI to advance from TRL 4 to TRL 6 through clinical-workflow integration, multicentre pilots, and regulatory-aligned validation supporting CE-IVDR Class IIb and FDA pathways.

In parallel, the project will consolidate its IP position, strengthen business readiness, and prepare for scale-up through Siemens Healthineers’ syngo.via Frontier ecosystem. By combining deep clinical reasoning with trustworthy, human-centred AI, BreastScreening-AI aims to become the European reference solution for early, accurate, and explainable breast cancer diagnostics.

Topics

Who is involved

OrganisationCityCountryRole
Sensiperception LdaCoimbraPortugalCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI